Literature DB >> 19255256

Distinctive roles of different beta-amyloid 42 aggregates in modulation of synaptic functions.

Hsueh-Cheng Chiang1, Koichi Iijima, Inessa Hakker, Yi Zhong.   

Abstract

To determine how endogenously secreted beta-amyloid 42 (Abeta42) aggregates regulate synaptic functions, we examined effects of Abeta42 at the neuromuscular junction of Drosophila larvae. Voltage-clamp recordings of synaptic transmission and optical analysis of vesicle recycling at presynaptic terminals show that expression of Abeta42 in neurons leads to a reduction of neurotransmitter release. However, expression of Abeta42 in postsynaptic muscle cells enhanced neurotransmitter release. Both effects are neutralized by Abeta antibody, suggesting a role for secreted Abeta42 peptides. Application of exogenously prepared Abeta42 oligomers leads to a reduction in synaptic responses, whereas mixed Abeta42 aggregates with mainly fibrils elicit an opposite effect by increasing synaptic transmission. Further analysis of long-term depression (LTD) confirms differential effects of different Abeta42 aggregates. Taken together, our data suggest that Abeta42 is secreted from neurons primarily as oligomers that inhibit neurotransmitter release and exert no effect on LTD. Whereas larger-sized aggregates, possibly fibrils, are major components secreted from muscle cells, which enhance synaptic transmission and LTD. Thus, different types of cells may secrete distinct forms of Abeta42 aggregates, leading to different modulation of synaptic functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255256      PMCID: PMC2698658          DOI: 10.1096/fj.08-121152

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  47 in total

1.  Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease.

Authors:  C A McLean; R A Cherny; F W Fraser; S J Fuller; M J Smith; K Beyreuther; A I Bush; C L Masters
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 2.  Drosophila models of human neurodegenerative disease.

Authors:  H Y Chan; N M Bonini
Journal:  Cell Death Differ       Date:  2000-11       Impact factor: 15.828

3.  Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Authors:  Dominic M Walsh; Igor Klyubin; Julia V Fadeeva; William K Cullen; Roger Anwyl; Michael S Wolfe; Michael J Rowan; Dennis J Selkoe
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

4.  Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

Authors:  Hai-Wei Wang; Joseph F Pasternak; Helen Kuo; Helen Ristic; Mary P Lambert; Brett Chromy; Kirsten L Viola; William L Klein; W Blaine Stine; Grant A Krafft; Barbara L Trommer
Journal:  Brain Res       Date:  2002-01-11       Impact factor: 3.252

5.  APP processing and synaptic function.

Authors:  Flavio Kamenetz; Taisuke Tomita; Helen Hsieh; Guy Seabrook; David Borchelt; Takeshi Iwatsubo; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

6.  Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.

Authors:  C W Wittmann; M F Wszolek; J M Shulman; P M Salvaterra; J Lewis; M Hutton; M B Feany
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

7.  Properties of the larval neuromuscular junction in Drosophila melanogaster.

Authors:  L Y Jan; Y N Jan
Journal:  J Physiol       Date:  1976-10       Impact factor: 5.182

8.  Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease.

Authors:  B Urbanc; L Cruz; R Le; J Sanders; K Hsiao Ashe; K Duff; H E Stanley; M C Irizarry; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-09       Impact factor: 11.205

9.  Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model.

Authors:  Jennifer Drake; Christopher D Link; D Allan Butterfield
Journal:  Neurobiol Aging       Date:  2003 May-Jun       Impact factor: 4.673

10.  Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

Authors:  Karie N Dahlgren; Arlene M Manelli; W Blaine Stine; Lorinda K Baker; Grant A Krafft; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

View more
  15 in total

1.  PI3 kinase signaling is involved in Abeta-induced memory loss in Drosophila.

Authors:  Hsueh-Cheng Chiang; Lei Wang; Zuolei Xie; Alice Yau; Yi Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 2.  Modeling the complex pathology of Alzheimer's disease in Drosophila.

Authors:  Pedro Fernandez-Funez; Lorena de Mena; Diego E Rincon-Limas
Journal:  Exp Neurol       Date:  2015-05-27       Impact factor: 5.330

3.  Cholesterol increases ventricular volume in a rabbit model of Alzheimer's disease.

Authors:  Stephen Deci; Susan K Lemieux; Carrie A Smith-Bell; D Larry Sparks; Bernard G Schreurs
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Ascidians: an invertebrate chordate model to study Alzheimer's disease pathogenesis.

Authors:  Michael J Virata; Robert W Zeller
Journal:  Dis Model Mech       Date:  2010-03-02       Impact factor: 5.758

5.  Inhibitory Effects of Quercetin on Muscle-type of Nicotinic Acetylcholine Receptor-Mediated Ion Currents Expressed in Xenopus Oocytes.

Authors:  Byung-Hwan Lee; Tae-Joon Shin; Sung-Hee Hwang; Sun-Hye Choi; Jiyeon Kang; Hyeon-Joong Kim; Chan-Woo Park; Soo-Han Lee; Seung-Yeol Nah
Journal:  Korean J Physiol Pharmacol       Date:  2011-08-31       Impact factor: 2.016

Review 6.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

7.  Apolipoprotein E-mimetics inhibit neurodegeneration and restore cognitive functions in a transgenic Drosophila model of Alzheimer's disease.

Authors:  Svetlana Sarantseva; Svetlana Timoshenko; Olga Bolshakova; Eugenia Karaseva; Dmitry Rodin; Alexander L Schwarzman; Michael P Vitek
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

8.  Intraneuronal accumulation of Aβ42 induces age-dependent slowing of neuronal transmission in Drosophila.

Authors:  Jing-Ya Lin; Wen-An Wang; Xiao Zhang; Hai-Yan Liu; Xiao-Liang Zhao; Fu-De Huang
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

9.  Characterization of a Drosophila Alzheimer's disease model: pharmacological rescue of cognitive defects.

Authors:  Ranjita Chakraborty; Vidya Vepuri; Siddhita D Mhatre; Brie E Paddock; Sean Miller; Sarah J Michelson; Radha Delvadia; Arkit Desai; Marianna Vinokur; David J Melicharek; Suruchi Utreja; Preeti Khandelwal; Sara Ansaloni; Lee E Goldstein; Robert D Moir; Jeremy C Lee; Loni P Tabb; Aleister J Saunders; Daniel R Marenda
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

10.  Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease.

Authors:  Kanae Iijima-Ando; Stephen A Hearn; Christopher Shenton; Anthony Gatt; Lijuan Zhao; Koichi Iijima
Journal:  PLoS One       Date:  2009-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.